tirzepatide surmount-1 weight loss percent nejm 2022 for Obesity Treatment and Diabetes Prevention Zepbound Clinical Trial Results: SURMOUNT-1

WHO SHOULD USE IT

The clinical guidelines and recommendations from esteemed health organizations such as the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) consistently endorse the use of GLP-1 analogues for specific patient associates

The key differences are the approved indication, the maximum dose, and how insurance handles each one

PlexusDx's compounded tirzepatide injection delivers the same active ingredient through licensed 503A pharmacies and has identical pharmacokinetics to brand-name formulations

Some pharmacies offer discounts or promotional codes for new customers, which can help reduce the overall cost

van der WagtIde JongICMitchellMAMolenaarRvan den BrandH